Corazon (A Division Of Arlak Biotech Private Limited)
Zirakpur, Mohali, Punjab
GST No. 03AAGCA5095C1Z1
TrustSEAL Verified
Call 07971375697 64% Response Rate
SEND EMAIL

Pharmaceutical Injection

Pioneers in the industry, we offer hydroxyprogesterone caproate( myterm-h ) 250 mg from India.

Hydroxyprogesterone Caproate( Myterm-H ) 250 mg

Hydroxyprogesterone Caproate( Myterm-H ) 250 mg
  • Hydroxyprogesterone Caproate( Myterm-H ) 250 mg
Get Best Quote
Approx. Price: Rs 89.00 / PackGet Latest Price

Product Details:

Packaging SizeDispo pack
BrandMyterm - H 250
CompositionHydroxyprogesterone Caporate
TreatmentHydroxyprogesterone caproate injection is a man-made progestin hormone. It is used in pregnant women
Prescription/Non prescriptionPrescription
Also GivesPCD Pharma Franchise, Third Party Manufacturing
Shelf Life2 years
FormInjection

Brand Name :- Myterm- H 250 
Composition :- Hydroxyprogesterone Caproate
Packing : Dispo pack 1 ml 
Mrp : 89.00

Reduces the risk of spontaneous Recurrent pre-term birth.
   
MEDICATION  USED FOR 

Myterm -H 250 ( Hydroxyprogesterone Caproate ) is a potent ,long-acting ,progestational steriod ester .Myterm-H 250 helps reducing the risk of preterm birth in women with a singleton Pregnancy who have a history of singleton spontaneous preterm birth .  Myterm -H 250  transforms prolifeative endothelium into secretory  endothelium , induces mammary gland duct development . 

Weekly injections of 17-alpha-hydroxyprogesterone caporate begining of 16-20 weeks gestation resulted in a substanital reduction in the rate of spontaneous  recurrent preterm birth. Long term  follow -up of children  exposed in -utero to the drug  has normal growth and development and normal scores for gender specific  roles . In Conclusion , 17 alpha-hydroxyprogesterone  caproate is currently the only drug with sufficient  evidence to support its use for prevention  of spontaneous recurrent preterm birth.


INDICATION 
In Pregnant women 

Preterm Labor

In Non -Pregnant Women 

For the treatment of advanced adenocarcinoma of the uterine corpus 
In the management of amenorrhea ( primary and secondary ) 
In the management of abnormal uterine bleeding due to hormonal imbalance  in the absence of organic pathology ,such as submucous fibroids or uterine cancer . 
Request
Callback
Yes! I am Interested
X

Explore More Product



Reach Us
Umesh Kalra (Marketing Manager)
Corazon (A Division Of Arlak Biotech Private Limited)
Sco-6,Near Sunpark Hotel,Wadhwa Nagar
Zirakpur - 140603, Mohali, Punjab, India


Call Us


Send E-mailSend SMS